Brief: Aegirbio And Undisclosed Partner Sign LoI
25/04/2025 09:31
April 25 (Reuters) - Magnasense AB MAGNA.ST: AEGIRBIO UK LTD AND UNDISCLOSED PARTNER SIGN LOI TO DEVELOP INNOVATIVE DIGITAL DIAGNOSTIC PRODUCT AEGIRBIO UK SIGNS LOI TO DEVELOP SALIVA-BASED DIAGNOSTIC PRODUCT PARTNER TO PROVIDE FUNDING AND OVERSEE REGULATORY APPROVALS LOI INCLUDES PROVISIONS ON IP RIGHTS AND EXCLUSIVITY Source text: ID:nMFN9SqmKK Further company coverage: MAGNA.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Subgen AI AB
See all newsBrief: Spanish Government Authorizes €19.2 Mln Investment In Subgen AI Unit
Brief: Subgen AI To Appeal Court Verdict Upholding SEK 12 Mln Regulatory Fine
Brief: Subgen AI Announces Outcome Of Directed Issue Of Shares
Brief: Subgen AI Plans Share Issue, Eyes 58.8% Substrate AI Stake
Brief: Subgen AI Says Administrative Court Upholds Fine On Magnasense